Essex Bio-Technology Limited (HKG:1061)
Hong Kong
· Delayed Price · Currency is HKD 3.950
+0.080 (2.07%)
At close: Mar 10, 2026
Essex Bio-Technology Revenue
Essex Bio-Technology had revenue of 876.54M HKD in the half year ending June 30, 2025, a decrease of -2.54%. This brings the company's revenue in the last twelve months to 1.72B, up 3.10% year-over-year. In the year 2024, Essex Bio-Technology had annual revenue of 1.67B, down -3.87%.
Revenue (ttm)
1.72B
Revenue Growth
+3.10%
P/S Ratio
1.28
Revenue / Employee
1.20M
Employees
1,426
Market Cap
2.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.67B | -67.16M | -3.87% |
| Dec 31, 2023 | 1.74B | 419.26M | 31.82% |
| Dec 31, 2022 | 1.32B | -319.95M | -19.54% |
| Dec 31, 2021 | 1.64B | 659.55M | 67.43% |
| Dec 31, 2020 | 978.11M | -301.37M | -23.55% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Golden Throat Holdings Group Company | 1.07B |
| JBM (Healthcare) | 812.98M |
| Jacobson Pharma Corporation | 1.53B |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |
| Hua Medicine (Shanghai) | 406.16M |
| VISEN Pharmaceuticals | 921.55K |
| Chia Tai Enterprises International | 4.17B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |